Term
|
Definition
a polysaccharide of glucose, for short term energy, storage in liver and muscle tissue |
|
|
Term
|
Definition
catabolism of glycogen to glucose (breakdown of glycogen) |
|
|
Term
|
Definition
rxns that convert glucose to pyruvic acid + ATP (energy for cells) |
|
|
Term
|
Definition
pancreatic hormone released when BG(blood glucose) low, causes liver to convert stored glycogen into glucose |
|
|
Term
|
Definition
GI hormone causing an ↑ in the amount of insulin released by the beta cells after eating |
|
|
Term
|
Definition
pancreatic peptide hormone secreted at the same time as insulin.
"synergistic partner" contributing to glycemic control |
|
|
Term
|
Definition
d/o of carbohydrate metabolism.
short term- hypo & hyper glycemia
long term- HTN, heart disease; blindness; renal failure; neuropathy(nerve pain); amputations; impotence; stroke |
|
|
Term
signs and symptoms of diabetes mellitus(DM) |
|
Definition
undiagnosed s/s: sustained hyperglycemia; polyuria (↑ urine output); polydipsia (↑ fluid intake[excessive thirst]); ketonuria (ketones in urine); weight loss
s/s result from a deficiency of insulin or resistance to insulin's actions. |
|
|
Term
types of diabetes mellitus (DM) |
|
Definition
type 1 (IDDM[insulin dependant diabetes mellitus], juvenile)- 5-10%- destruction of pancreatic beta cells (autoimmune process)
type 2 (NIDDM[non-insulin dependant diabetes mellitus])- 22 millionamericans- insulin resistance & impaired insulin secretion
gestational diabetes- appears during pregnancy, subsiding rapidly after delivery
management: diet, exercise, medication (insulin, antihypertensives & cholesterol lower medications)
glycemic index= regulation of blood glucose levels |
|
|
Term
|
Definition
FSBG(finger stick blood glucose) & SMBG (self monitoring blood glucose): use a glucometer before meals (AC) & at bedtime (HS)
Target: 70-130mg/dL (AC); 100-140 mg/dL (HS) |
|
|
Term
insulin
type 1 and some type 2
stimulates cellular transport of glucose into the cells, and stored as glycogen; promotes synthesis of complex organic molecules |
|
Definition
can't give PO- destroyed by digestive system
Use: diabetes; diabetic ketoacidosis; hyperkalemia
Effects: lowers serum glucose levels
AE: hypoglycemia; lipodystrophies[occurs when using same sit all the time](lipoatrophy & lipohypertrophy[enlargement of area]); allergic rxn; hypokalemia w/ excessive doses
DD: hypoglycemic agents; hyperglycemic agents; ETOH(acute use); beta blockers(masks s/s of hypoglycemia); glucocorticoids; sympathomimetics |
|
|
Term
treating hypoglycemia(BG less < 50 mg/dL) |
|
Definition
Dextrose- IV; given for severe hypoglycemia; prefilled syringe
Glucagon- insulin overdose; raises BG levels (promotes breakdown of glycogen synthesis & stimulates biosynthesis of glucose); use in unconscious patients. |
|
|
Term
|
Definition
short duration, rapid acting: Humalog: onset- 15-30 min, duration- 3-6 hr; Novolog: onset- 10-20 min, duration- 3-5 hr; Apidra: onset 10-15 min, duration- 3-5 hr
short duration, slower acting: Humilin R: onset- 30-60 min, peak: 1-5 hr, duration- 10 hr
all clear in color |
|
|
Term
intermediate duration insulin |
|
Definition
NPH: allergy potential (due to protamine-foreign protein); cloudy in color; only one that can be mixed w/ short duration insulin
detemir(levemir): low doses- duration 12 hr; high doses- duration 24 hr |
|
|
Term
|
Definition
glargine(Lantus): only once daily
24 hr duration |
|
|
Term
|
Definition
NPH & regular or Aspart protamine, Lispro protamine w/ aspart or lispro |
|
|
Term
|
Definition
injection site: upper arms, thighs, abdomen(prefered site); rotate sites w/in general area
syringe & needle
given in units. U100 or U500
pen injector- prefilled cartridge
jet injector- no needle
pumps- infusion SQ of regular, lispro, aspart or glulisine(short duration insulins). |
|
|
Term
|
Definition
causes: not eat enough, too much insulin or oral agent, too much activity
s/s: shaking, ↑ HR, sweating, dizzy, faint, anxious, hungry, impaired vision, weakness & fatigue, HA(headache), emotional changes
Tx: simple sugar followed w/ complex carbohydrate |
|
|
Term
|
Definition
causes: too little insulin or oral agent, too much food
s/s: extreme thirst, frequent urination, blurred vision, weakness & fatigue, HA, N, V, abd cramps, hunger followed by ↓ appetite
Tx: insulin, fluids |
|
|
Term
metformin(glucophage)
oral hypoglycemics- biguanides
↓ glucose production in liver; ↓ absorption of glucose in gut; enhances muscle utilization of glucose |
|
Definition
Use: type 2 diabetes
Effects: lowers serum glucose levels
AE: ↓ appetite, N, D; ↓ absorption of vitamin B12 & folic acid
Toxicity: lactic acidosis by inhibition of oxidation of lactic acid (rare, but 50% mortality rate), usually r/t renal insufficiency
DD: ETOH (↑ risk of lactic acidosis); IV contrast w/ iodine(↑ risk of lactic acidosis), stop 48 hr prior to test & restart 48 hr after procedure
needs annual labs to check vitamin levels |
|
|
Term
tolbutamide (Orinase)
oral hypoglycemic- sulfonylureas
stimulates release of insulin from pancreas |
|
Definition
Use: type 2 diabetes; adjunct to diet/exercise program
Effects: lowers serum glucose levels
AE: hypoglycemia (fatigue, excessive hunger, profuse sweating, palpitations); avoid in pregnancy
DD: ETOH (disulfiram-like rxn, intensify hypoglycemia); NSAIDs (intensify hypoglycemia); sulfonamide antibiotics (intensify hypoglycemia); beta blockers (supress insulin release |
|
|
Term
pioglitazone (Actos)
glitazones aka TZDs
↓ insulin resistance |
|
Definition
Use: type 2 diabetes
Effects: reduce blood glucose levels
AE: URI(upper respiratory infection), HA, sinusitis (sinus infection), myalgia (tenderness or pain in the muscles); fluid retention, edema; raises HDL, LDL and ↓ triglycerides; less hepatotoxicity but monitor ATL (liver) levels
DD: atorvastain (Lipitor) - leads to ↑ drug level and hypoglycemia
if pt is premenopausal drug can stimulate ova production, leading to unplanned/unexpected pregnancy. |
|
|
Term
repaglinide (Prandin)
glinides aka megalitinides
stimulates release of insulin from pancreas |
|
Definition
Use: type 2 diabetes
Effect: lowers serum glucose levels
AE: hypoglycemia
DD: gemfribrozil (Lopid) - inhibits metabolism of prandin leading to ↑ levels and hypoglycemia |
|
|
Term
acarbose (Precose)
alpha-glucosidase inhibitor
delays absorption of carbohydrates from intestine |
|
Definition
Use: type 2 diabetes
Effects: reduces rise in blood glucose after meals
AE: flatulence, cramps, abd distention, borborygmus (loud bowel sounds), D, liver dysfunction
|
|
|
Term
sitagliptin (Januvia)
gliptins (DPP-4 inhibitor) - new class
prolongs active incretin levels, that ↑ insulin release and suppress release of glucagon |
|
Definition
Use: type 2 diabetes
AE: HA, URI, hypoglycemia; rare: pancreatitis & severe hypersensitivity (allergic rxn)
ADJUST DOSE IN RENAL FAILURE PATIENTS
DD: none
|
|
|
Term
|
Definition
T3 (triodothyonine - more potent) & T4 (tetraiodothyronine or thyroxine)
stimulate energy use - ↑ basal metabolic rate, O2 use & heat production
stimulate heart - ↑ HR & force of contraction, ↑ CO2, ↑ O2 demand
promote growth & development - brain, nervous system & skeletal muscle
low iodine - ↓ production of thyroid hormones; thyroid increases in size (goiter) & concentrates iodine |
|
|
Term
levothyroxine (Synthroid)
synthetic preparation of thyroxine (T4)
similar to thyroid hormone action |
|
Definition
Use: hypothyroidism
Effects: ↑ thyroxine (T4) levels; ↑ T3 levels
AE: thyrotoxicosis (excessive dosages) - tachycardia, angina (chest pain), tremors, nervousness, insomnia, hyperthermia, heat intolerance, diaphoresis (sweating)
DD: drugs that ↓ levothyroxine absorption: H2 receptor blocker, PPI & Sulcralfate (GI protectant drugs); cholestyramine & cholestipol; calcium & Fe supplements; Mg salts
phentoin (Dilantin), cambamazepine (Tegretol), seraline (Zoloft), phenobarbital ↑ metabolism of levothyroxine so may need to ↑ dose
drug given in mcg; best absorbed on an empty stomach |
|
|
Term
methimazole (Tapazole)
blockade of thyroid hormone synthesis; suppresses conversion of T4 to T3 |
|
Definition
Use: Grave's disease (hyperthyroidism); radiation therapy adjunct; pre-op in prep to remove portion of thyroid
Effects: lower T3 & T4 levels
AE: agranulocytosis (lack of WBCs); hypothyroidism; caution in pregnancy (crosses placenta and mammory glands); rash
|
|
|
Term
propylthiouracil (PTU)
used for emergencies |
|
Definition
Action and Effect similar to Tapazole
Use: thyrotoxic crisis ("thyroid storm")
AE: can cause liver injury
|
|
|
Term
vasopressin (Pitressin)
promotes renal conservation of H2O; vasoconstriction
drug for hypothalamus d/o's |
|
Definition
Use: diabetes insipidus (ADH deficiency)
Effects: ↓ diuresis (urine output)
AE: H2O intoxication r/t excessive H2O retention (early s/s drowsiness, listless); HA; severe s/s: convlusions, terminal coma; cardiac - a.p. r/t coronary artery constriction
|
|
|
Term
hydrocortisone (synthetic equivalent to cortisol), desamethasone, prednisone
drug for adrenal d/o's |
|
Definition
Use: replacement therapy for adrenocortical insufficiency
Effects: improve carbohydrate metabolism, promotes glucose availability to the brain
AE: rare when used for endocrine d/o's
|
|
|
Term
hormone replacement therapy |
|
Definition
estrogen, progestin & combo
controversy r/t effects on uterine CA, breast CA, thromboembolism, ↑ bone density
|
|
|
Term
|
Definition
conjugated estrogens (Premarin - from horse urine), Estradiol (Estrace)
"Bio-identical hormones": estradiol, estriol, estrone
used if women has no uterus |
|
|
Term
|
Definition
Progesterone (Prometrium, medroxyprogesterone (Provera))
combination: Prempro
pregestin and comvo given if uterus is present
progestion protects endometrium to present hyperplasia and cancer |
|
|